Globeflex Capital L P Black Diamond Therapeutics, Inc. Transaction History
Globeflex Capital L P
- $592 Million
- Q3 2025
A detailed history of Globeflex Capital L P transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Globeflex Capital L P holds 305,276 shares of BDTX stock, worth $1.4 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
305,276Holding current value
$1.4 Million% of portfolio
0.19%Shares
1 transactions
Others Institutions Holding BDTX
# of Institutions
100Shares Held
44.8MCall Options Held
0Put Options Held
0-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.5MShares$48.3 Million0.02% of portfolio
-
Vestal Point Capital, LP New York, NY5.6MShares$25.7 Million0.73% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$20.4 Million0.91% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$14.8 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.73MShares$12.5 Million0.15% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $167M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...